The Allstate Corporation »

Lenz Therapeutics shares owned by The Allstate Corporation

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by The Allstate Corporation from 13F filings

Historical chart of The Allstate Corporation investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by The Allstate Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by The Allstate Corporation

Quarter filed Position value Share count Share price at filing
2026-06-30 $200k 35k 5.68

More positions owned by The Allstate Corporation

Vanguard St Corp Bd Etf Equity (VCSH)
Ishares:core S&p Tot Usm Equity (ITOT)
Ishares:1-5 Ig Corp Bd Equity (IGSB)
Ishares:5-10 Ig Corp Bd Equity (IGIB)
Ishares:natl Muni Bond Equity (MUB)
Amazon Com Ord Equity (AMZN)
Apple Ord Equity (AAPL)
Nvidia Ord Equity (NVDA)
Microsoft Ord Equity (MSFT)
Broadcom Ord Equity (AVGO)
Ss Spdr Ptf St Corp Bond Equity (SPSB)
Alphabet Cl A Ord Equity (GOOGL)
Micron Technology Ord Equity (MU)
Ishares:core S&p 500 Equity (IVV)
Meta Platforms Cl A Ord Equity (META)

View all positions for The Allstate Corporation

Top funds holding Lenz Therapeutics

RA Capital Management
Falcon Edge Capital
FMR
Versant Venture Management
BlackRock
Squarepoint Ops
Standard Life Aberdeen
Millennium Management
Vanguard Capital Management
72 Investment Holdings
Blue Owl Capital Holdings
CAM Group Holding A/S
Morgan Stanley
Citadel Advisors
Geode Capital Management

View all funds holding Lenz Therapeutics